Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,870 | 617 | 99.8% |
| Education | $21.60 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,205 | 90 | $0 (2024) |
| ABBVIE INC. | $883.97 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $767.63 | 48 | $0 (2024) |
| PFIZER INC. | $749.41 | 64 | $0 (2024) |
| Novo Nordisk Inc | $739.71 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $507.73 | 45 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $501.43 | 31 | $0 (2024) |
| Amgen Inc. | $420.33 | 27 | $0 (2023) |
| Lilly USA, LLC | $406.71 | 32 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $280.13 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,147 | 68 | PFIZER INC. ($166.13) |
| 2023 | $1,066 | 65 | GlaxoSmithKline, LLC. ($187.68) |
| 2022 | $1,284 | 81 | ABBVIE INC. ($212.82) |
| 2021 | $1,174 | 79 | AbbVie Inc. ($179.48) |
| 2020 | $620.97 | 45 | GlaxoSmithKline, LLC. ($154.38) |
| 2019 | $1,175 | 86 | GlaxoSmithKline, LLC. ($162.12) |
| 2018 | $1,184 | 99 | Janssen Pharmaceuticals, Inc ($187.60) |
| 2017 | $1,239 | 98 | GlaxoSmithKline, LLC. ($184.67) |
All Payment Transactions
621 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Gastroenterology | ||||||
| 12/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Diabetes Care | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: VACCINES | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Obesity | ||||||
| 09/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: UROLOGY | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: VACCINES | ||||||
| 07/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PAIN | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: UROLOGY | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,512 | 1,929 | $382,586 | $165,723 |
| 2022 | 17 | 1,522 | 1,828 | $342,027 | $156,295 |
| 2021 | 19 | 1,723 | 2,064 | $294,688 | $151,715 |
| 2020 | 25 | 2,230 | 2,820 | $332,503 | $156,747 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 492 | 823 | $151,407 | $66,009 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 491 | 491 | $152,701 | $60,251 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 216 | $27,842 | $13,462 | 48.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 40 | 40 | $21,160 | $11,243 | 53.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 78 | 79 | $7,469 | $5,662 | 75.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 84 | 85 | $3,485 | $2,438 | 70.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,118 | $2,208 | 53.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 37 | 43 | $5,848 | $1,613 | 27.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,640 | $1,147 | 70.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 26 | 26 | $3,078 | $851.70 | 27.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 15 | $1,230 | $285.75 | 23.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 28 | $1,288 | $244.27 | 19.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 18 | $792.00 | $212.10 | 26.8% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 11 | 11 | $528.00 | $97.21 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 481 | 716 | $131,744 | $56,865 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 438 | 438 | $118,263 | $54,614 | 46.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 48 | 48 | $25,392 | $13,349 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 166 | $21,392 | $9,820 | 45.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 85 | 85 | $7,553 | $5,806 | 76.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 22 | 22 | $6,314 | $3,529 | 55.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 21 | 21 | $6,939 | $3,381 | 48.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 87 | 87 | $3,567 | $2,364 | 66.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 68 | 68 | $2,788 | $1,853 | 66.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 32 | 34 | $4,624 | $1,351 | 29.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 34 | 34 | $3,842 | $1,168 | 30.4% |
About Dr. Dustan Buckley, MD
Dr. Dustan Buckley, MD is a Internal Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730171794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dustan Buckley, MD has received a total of $8,892 in payments from pharmaceutical and medical device companies, with $1,147 received in 2024. These payments were reported across 621 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,870).
As a Medicare-enrolled provider, Buckley has provided services to 6,987 Medicare beneficiaries, totaling 8,641 services with total Medicare billing of $630,480. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Oklahoma City, OK
- Active Since 08/16/2005
- Last Updated 05/16/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730171794
Products in Payments
- TRELEGY ELLIPTA (Drug) $696.31
- JARDIANCE (Drug) $465.40
- FARXIGA (Drug) $459.13
- Ozempic (Drug) $359.91
- LINZESS (Drug) $309.01
- XARELTO (Drug) $299.73
- ANORO (Drug) $277.66
- GEMTESA (Drug) $255.82
- ENTRESTO (Drug) $249.63
- XIFAXAN (Drug) $238.50
- CHANTIX (Drug) $217.58
- INVOKANA (Drug) $208.00
- TRULICITY (Drug) $184.66
- Vascepa (Drug) $172.01
- ELIQUIS (Drug) $165.44
- NURTEC ODT (Drug) $161.96
- FREESTYLE LIBRE 3 (Device) $156.29
- Creon (Drug) $149.02
- Rybelsus (Drug) $143.24
- Otezla (Drug) $137.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oklahoma City
John Kingrey, Md, MD
Internal Medicine — Payments: $325,421
Dr. Jeffrey Sparling, M.d, M.D
Internal Medicine — Payments: $289,451
Dr. Romeo Mandanas, M.d, M.D
Internal Medicine — Payments: $275,924
Marcus Smith, Md, MD
Internal Medicine — Payments: $181,269
Dr. Ryan Morgan, D.o, D.O
Internal Medicine — Payments: $126,341
Usman Baber, Md, MD
Internal Medicine — Payments: $76,000